From the newsletter
Africa is beginning to turn healthcare spending into an engine for industrial growth. Kenya's new five-year pharma manufacturing strategy offers one of the continent's clearest blueprints on using government purchasing power to build a pharmaceutical industry that can replace imports and compete in regional markets.
The strategy tackles one of Africa's biggest manufacturing challenges: governments are the largest buyers of medicines, yet local pharmaceutical companies often operate far below capacity because public procurement does little to create predictable demand.
The Kenyan strategy, titled Kenya Health Products and Technologies Local Manufacturing Strategy 2026 – 2030, combines guaranteed demand, procurement preferences for locally manufactured products, coordinated purchasing and faster payments to suppliers, creating a more predictable market that gives manufacturers the confidence to invest.
More details